Evidence map›Paper›PMID 38904363›Full record

ArticlemSphere2024

Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis.

Wei-Chiao Huang, Karen Eberle, Jonothan Rosario Colon, Jonathan F Lovell, Hong Xin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Advancing Peptide-Based Vaccines AgainstJournal of fungi (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Innovative antifungal strategies to combat drug-resistantFrontiers in cellular and infection microbiology · 2025
    Review
  6. Unveiling the mechanisms of synthetic compounds againstCurrent research in pharmacology and drug discovery · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei-Chiao HuangDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, New York, USA.
Karen EberleDepartment of Microbiology, Immunology & Parasitology, LSU Health Sciences Center New Orleans, New Orleans, Louisiana, USA.
Jonothan Rosario ColonDepartment of Microbiology, Immunology & Parasitology, LSU Health Sciences Center New Orleans, New Orleans, Louisiana, USA.
Jonathan F LovellDepartment of Biomedical Engineering, State University of New York at Buffalo, Buffalo, New York, USA.ORCID 0000-0002-9052-884X
Hong XinDepartment of Microbiology, Immunology & Parasitology, LSU Health Sciences Center New Orleans, New Orleans, Louisiana, USA.ORCID 0000-0002-9709-9267

Funding

Development of immunotherapeutic strategies and vaccines against multidrug resistant C. auris disseminated infectionR21AI168929 · NIAID · LSU HEALTH SCIENCES CENTER · PI XIN, HONG · 2022 to 2023
$404k
NIAID NIH HHS R21 AI168929
6 · The paper itself

Abstract

Epitopes from the IMPORTANCE: This study introduces a promising vaccine strategy against invasive candidiasis, a severe fungal infection, by targeting specific peptides on the surface of

Indexed as

Antibodies, FungalCandidiasisFungal VaccinesLiposomesMice, Inbred BALB CAdjuvants, ImmunologicAnimalsAntigens, FungalCandidaCandida albicansCytokinesDisease Models, AnimalFemaleFungal ProteinsImmunoglobulin GMiceAdjuvants, ImmunologicAntibodies, FungalAntigens, FungalCytokinesFungal ProteinsFungal VaccinesImmunoglobulin GLiposomesVaccines, Subunitcandidiasisspontaneous nanoliposome antigen particlevaccines

Identifiers

PMID38904363
PMCPMC11287991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.